Gao S Z, Hunt S A, Schroeder J S, Alderman E L, Hill I R, Stinson E B
Division of Cardiovascular Medicine, Stanford University School of Medicine, California 94305-5246, USA.
J Am Coll Cardiol. 1996 Sep;28(3):673-9. doi: 10.1016/0735-1097(96)00201-x.
This study assessed the time of first appearance of angiographic graft coronary artery disease in relation to clinical and laboratory variables and clinical events in heart transplant recipients.
Graft coronary artery disease is the main factor limiting long-term survival after heart transplantation, and it is important to understand its natural history.
One hundred thirty-nine consecutive patients who developed angiographic coronary artery disease after heart transplantation were classified according to early (< or = 2 years) versus late (> 2 years) posttransplantation initial detection of coronary artery disease. These subgroups were analyzed for differences in clinical and laboratory demographics, incidence of progression to ischemic events and incidence of antecedent cytomegalovirus infection.
The early-onset group (64 patients) had more rapid progression to ischemic events than the late-onset group (75 patients), with 59% of the late group and only 35% of the early group free from ischemic events by 5 years after initial detection (p = 0.02), but there were no significantly correlated clinical or laboratory predictors of ischemic events. The early group had a significantly higher incidence of antecedent cytomegalovirus infection.
We conclude that 1) accelerated graft coronary artery disease develops at variable times after heart transplantation; 2) the early appearance of graft coronary artery disease may be a marker of intrinsically more aggressive disease; 3) cytomegalovirus infection is associated with earlier onset of graft coronary artery disease. Patients with early development of graft coronary artery disease should potentially be given priority for interventional strategies as they are developed.
本研究评估了心脏移植受者中血管造影显示的移植冠状动脉疾病首次出现的时间与临床和实验室变量以及临床事件的关系。
移植冠状动脉疾病是限制心脏移植后长期生存的主要因素,了解其自然病史很重要。
139例心脏移植后发生血管造影冠状动脉疾病的连续患者,根据移植后冠状动脉疾病初始检测的早期(≤2年)与晚期(>2年)进行分类。分析这些亚组在临床和实验室人口统计学、进展为缺血事件的发生率以及既往巨细胞病毒感染发生率方面的差异。
早期发病组(64例患者)比晚期发病组(75例患者)进展为缺血事件的速度更快,在初始检测后5年时,晚期组59%无缺血事件,而早期组仅35%无缺血事件(p=0.02),但缺血事件无显著相关的临床或实验室预测因素。早期组既往巨细胞病毒感染的发生率显著更高。
我们得出以下结论:1)心脏移植后不同时间会出现加速的移植冠状动脉疾病;2)移植冠状动脉疾病的早期出现可能是内在更具侵袭性疾病的一个标志;3)巨细胞病毒感染与移植冠状动脉疾病的较早发病有关。移植冠状动脉疾病早期发生的患者在制定干预策略时可能应优先考虑。